Pacer Advisors
IDYA icon

Pacer Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Pacer Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
+1,071
New +$32.8K ﹤0.01% 2095
2024
Q3 		– Sell
-683
Closed -$24K – 2617
2024
Q2 		$24K Sell
683
-252
-27% -$9.98K ﹤0.01% 3392
2024
Q1 		$41K Buy
+935
New +$40.2K ﹤0.01% 3252

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Pacer Advisors's IDYA Position: Q2 2026 in Review

Pacer Advisors opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 1,071 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #2095 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in IDYA as recently as Q2 2024.

Pacer Advisors first reported a position in IDYA in Q1 2024 and has held it in 3 quarters since. The position peaked at $41K in Q1 2024. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Pacer Advisors held 1,071 shares of IDEAYA Biosciences worth $40K as of Q2 2026.
  • IDEAYA Biosciences was a new Pacer Advisors position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2095 holding.
  • Pacer Advisors first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 3 quarters since.
  • Pacer Advisors's IDEAYA Biosciences position peaked at $41K in Q1 2024.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.